Genelux (GNLX) Accumulated Depreciation (2022 - 2026)
Genelux (GNLX) posted quarterly Accumulated Depreciation of $3.9 million for Q1 2026, little changed quarter-over-quarter from $3.9 million in Q4 2025.
Genelux (GNLX) Accumulated Depreciation (2022 - 2026) Analysis & Trends
Genelux's Accumulated Depreciation history runs 5 years deep, the most recent figure standing at $3.9 million for Q1 2026.
- In Q1 2026, Accumulated Depreciation changed N/A year-over-year to $3.9 million; the TTM figure through Mar 2026 stood at $3.9 million (changed N/A YoY), while the FY2025 annual figure was $3.9 million, up 6.6% from the prior year.
- Accumulated Depreciation for Q1 2026 stood at $3.9 million, roughly flat from $3.9 million in the prior quarter.
- The five-year high for Accumulated Depreciation was $3.9 million in Q1 2026, with the low at $2.9 million in Q4 2022.
- The 5-year median for Accumulated Depreciation is $3.7 million (2024), against an average of $3.6 million.
- The sharpest annual moves came in 2023 and 2025: Accumulated Depreciation increased 16.92% in 2023, then advanced 6.58% in 2025.
- Genelux's Accumulated Depreciation stood at $2.9 million in 2022, then advanced by 16.92% to $3.4 million in 2023, then advanced by 6.81% to $3.7 million in 2024, then increased by 6.6% to $3.9 million in 2025, then increased by 0.25% to $3.9 million in 2026.
- Business Quant data shows GNLX's Accumulated Depreciation at $3.9 million in Q1 2026, $3.9 million in Q4 2025, and $3.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Genelux | 119.87 Mn | 119.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.94 Mn |
| Dec 31, 2025 | 3.93 Mn |
| Sep 30, 2025 | 3.87 Mn |
| Jun 30, 2025 | 3.81 Mn |
| Dec 31, 2024 | 3.68 Mn |
| Sep 30, 2024 | 3.63 Mn |
| Jun 30, 2024 | 3.57 Mn |
| Mar 31, 2024 | 3.53 Mn |
| Dec 31, 2023 | 3.45 Mn |
| Dec 31, 2022 | 2.95 Mn |